NCT05051943View on ClinicalTrials.gov

A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response

CompletedOBSERVATIONAL
Enrollment

754

Participants

Timeline

Start Date

September 29, 2020

Primary Completion Date

January 20, 2023

Study Completion Date

January 20, 2023

Conditions
Crohn DiseaseUlcerative ColitisPsoriasisAnkylosing SpondylitisRheumatoid ArthritisPsoriatic Arthritis
Trial Locations (1)

54511

CHRU de Nancy - Hôpitaux de Brabois, Vandœuvre-lès-Nancy

Sponsors

Lead Sponsor

Fresenius Kabi
All Listed Sponsors
lead

Fresenius Kabi

INDUSTRY

NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response | Biotech Hunter | Biotech Hunter